FDA Inspection 1017306 — Cooper Institute For Advanced Reproductive Medicine
The FDA completed an inspection of Cooper Institute For Advanced Reproductive Medicine on Apr 26, 2017 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 26, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Houston, TX (United States)